In AD pathology, H4K12la promotes pathology by regulating key glycolytic enzyme genes (such as PKM2), whereas H3K18la acts through the regulation of inflammation-related signaling pathways (such as NF-κB). The gene discussed is NFKB1; the disease is Alzheimer disease.